about
P361
Peroxisome proliferator activated receptor gammaNuclear receptor subfamily 1 group H member 4Insulin IIPOMCPro-opiomelanocortin-alphaGlucokinaseInsulin receptorAdiponectin, C1Q and collagen domain containingCD36 moleculeBeta-site APP-cleaving enzyme 2Interleukin 6Glucose-6-phosphate isomerase 1Cryptochrome 1 (photolyase-like)Insulin-like growth factor I receptorCaveolin 3Glucagon receptorNuclear receptor subfamily 1, group H, member 4Protein tyrosine phosphatase, non-receptor type 11Calcium channel, voltage-dependent, L type, alpha 1C subunitCyclin dependent kinase inhibitor 2ABCL2-associated agonist of cell deathSolute carrier family 30 (zinc transporter), member 8Retinol binding protein 4, plasmaSignal transducer and activator of transcription 3Transcription factor 7 like 2Transcription factor 7 like 2, T cell specific, HMG boxNuclear receptor co-repressor 2Paired box 6Solute carrier family 18 (vesicular monoamine), member 2Transient receptor potential cation channel, subfamily V, member 4Insulin receptor substrate 1Insulin like growth factor 1 receptor2'-5'-oligoadenylate synthetase 1Parkinsonism associated deglycaseAdaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2FAM3 metabolism regulating signaling molecule BForkhead box protein O6Forkhead box O3Forkhead box O1HNF1 homeobox A
P682
Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertensionPAX6 mutation as a genetic factor common to aniridia and glucose intoleranceThe mitochondrial Ca2+ uniporter MCU is essential for glucose-induced ATP increases in pancreatic β-cellsPolymorphic variations in the neurogenic differentiation-1, neurogenin-3, and hepatocyte nuclear factor-1alpha genes contribute to glucose intolerance in a South Indian populationRetinol-binding protein 4 in human obesityInsulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutationsHypoglycemia due to a disorder of adrenal cortical regulationMutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1aUSF1 on trialHigh frequency of missense mutations in glycogen storage disease type VINew susceptibility loci in MYL2, C12orf51 and OAS1 associated with 1-h plasma glucose as predisposing risk factors for type 2 diabetes in the Korean populationGlucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study.Bace2 is a β cell-enriched protease that regulates pancreatic β cell function and mass.
P921
Q1084878-1AD44628-7228-44DB-AFC1-8792565C0AF9Q1085078-4100901A-5A04-425F-B859-25B29544B155Q14762286-1E730C28-21B8-43FC-A2C4-03BD4412264FQ14762286-7916F84F-7AFF-4778-9F6D-ED966FF35B89Q14819793-3B47E998-C350-4D0D-AC70-1209CBFE01EAQ14819798-483881ED-3B69-4577-8209-B58AE5C85E8BQ14863086-3BA89A95-69DD-44E8-B218-70E04E95079EQ14863366-4556DE39-F453-46A1-A3FC-E7727AD2F5C8Q14863366-973522C5-FC39-4E00-BBC6-F6BFB31D46FCQ14864062-324D241C-48AD-48A8-AF7F-0E534911EA15Q14864583-0FA1783B-321F-4BE2-86E4-4A454BADF398Q14865204-44CFE858-BAC0-4107-8EA3-B30CCF70C082Q14865240-7A757F41-A14E-4129-8DA7-409FBA7FCFA4Q14865772-2757DC0D-8ED6-43FE-9A57-D35F73AF1F0AQ14866013-1CC16A7C-0037-4C62-8D01-917CF59CF6F5Q14901460-58B51EE1-481D-4754-B11F-B37D5E7CFF5EQ14901728-33AF75DB-E03D-466E-8E6D-7DB30FBEFDE8Q14904914-490757BB-EDF0-4798-A1C0-72FB57FB7431Q14905046-E23EF931-4A47-46EA-A74D-C7A355DFBBF9Q14905498-B07A483E-001E-488B-8CFD-7C1B17518F4AQ14905748-6AC64CDE-9A56-47E0-B833-967CAB946A82Q14907028-8ACCAD62-8CCF-47CC-9788-A6C7025B43E3Q14907028-E6C1FA24-A7E9-4A2E-B714-4F6EBA815142Q14907709-951D5ADC-E356-42C0-AFBF-58C0258053CCQ14907993-5026D305-6ED0-428F-B088-41E27159A903Q14911603-F0BEB864-C9D3-4BA2-8EAC-EEE974F3C1E4Q14912021-1404B96B-F2B9-40FD-AF45-B7B8EB0ED77DQ14913880-B443A302-1F3F-4F11-A8EF-30C333B95EF0Q14913880-EEAA4836-B6FF-42DC-BB24-C7505D83BD2AQ14913903-5EDB38A0-ED19-4230-B432-80DD765E2685Q14913903-C82C5BA8-5283-4DC5-82C6-F633A40AFD0CQ14914612-BB96E75D-FEC2-49B1-9DBA-CC159F1C50A6Q14916221-89F93EE7-833F-42E8-976C-5962059B1D7EQ14916237-8A7984C0-23FF-4220-BE31-533E84BC101FQ15324125-D0CF11B4-5A10-49B3-8B09-62B910297A2DQ1665322-1A58E51B-A96E-4D3C-9F2C-D3FFD70AF7C3Q2005209-0AA0B96F-524E-4AA7-8648-0B4330397763Q21096374-69B5F2BE-DAE9-4460-8AA1-FDD04413949CQ21097342-12B1941E-16E5-4AD7-B1F9-3FBE35C18514Q21100937-008B6B27-05E7-47F1-A06E-56E953C272B2
P682
Q22011018-E45C50B0-731A-49E7-814C-4E4B444A0E74Q24292062-90FBE13F-395B-4067-89D7-B92F242CD8C0Q24294221-47FEF438-439F-4C7D-92F6-0F709B357328Q24300090-56E35C0B-0F12-4598-82D4-95230B0E552DQ24304905-CC19F0A6-3FC4-4613-BF13-302D0C889A5BQ24308042-2B58205A-C827-4B88-827F-E641199C0F80Q24316870-6E2B9BB9-1F65-40D1-B4A5-6098A6039521Q24317268-7A89A9EF-4642-4ECF-B958-1823C2B8B8E1Q24322826-591207CE-F172-49BA-B139-394D5F3F4C1DQ24337771-7C4D3AAC-C32F-4B6F-BC6A-0D9DBA97F1B3Q24338244-9EE1D82A-8BEA-44A0-BE33-1008BBD45913Q42699213-07892ebc-4242-51ec-1aa9-c6883128916aQ42726932-56C241F8-ED3C-43DD-89F4-98F521FFD8BE
P921
description
Any process involved in the ma ...... se within an organism or cell.
@en
biologisch proces
@nl
name
glucose homeostasis
@en
glukosehomeostase
@nn
homeostaza glukoze
@sr-el
хомеостаза глукозе
@sr
хомеостаза глукозе
@sr-ec
type
label
glucose homeostasis
@en
glukosehomeostase
@nn
homeostaza glukoze
@sr-el
хомеостаза глукозе
@sr
хомеостаза глукозе
@sr-ec
altLabel
GO:0042593
@en
prefLabel
glucose homeostasis
@en
glukosehomeostase
@nn
homeostaza glukoze
@sr-el
хомеостаза глукозе
@sr
хомеостаза глукозе
@sr-ec
P2888
P527
P686
GO:0042593